LIFECORE BIOMEDICAL, INC. Gain (Loss) Related to Litigation Settlement
LIFECORE BIOMEDICAL, INC. (LFCR) reported Gain (Loss) Related to Litigation Settlement of $0 for the 12-month period ending 2019-05-26, per its 10-K filed 2019-08-01.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2019-08-01
- LIFECORE BIOMEDICAL, INC. gain (loss) related to litigation settlement for the quarter ending 2017-05-28 was $0.00.
- LIFECORE BIOMEDICAL, INC. gain (loss) related to litigation settlement for the quarter ending 2017-02-26 was -$2.08M.
- LIFECORE BIOMEDICAL, INC. gain (loss) related to litigation settlement for fiscal 2019 was $0.00.
- LIFECORE BIOMEDICAL, INC. gain (loss) related to litigation settlement for fiscal 2018 was $0.00.
- LIFECORE BIOMEDICAL, INC. gain (loss) related to litigation settlement for fiscal 2017 was -$2.58M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2019-05-26 | $0.00 10-K · filed 2019-08-01 | |||
| 2018-05-27 | $0.00 10-K · filed 2019-08-01 | |||
| 2017-05-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | -$2.08M derived: sum of 2 quarters · filed 2019-08-01 | -$2.58M 10-K · filed 2019-08-01 | |
| 2017-02-26 | -$2.08M 10-Q · filed 2018-04-05 | -$2.58M 10-Q · filed 2018-04-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |